Last Updated: June 23, 2026

PRUCALOPRIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Prucalopride patents expire, and what generic alternatives are available?

Prucalopride is a drug marketed by Ajanta Pharma Ltd, Alkem Labs Ltd, Amneal, Annora Pharma, Apotex, Appco, H2-pharma, Hikma, Lupin, MSN, Novitium Pharma, Somerset Therap, Specgx Llc, Teva Pharms Inc, Torrent, Zenara, and Zydus Lifesciences. and is included in seventeen NDAs.

The generic ingredient in PRUCALOPRIDE is prucalopride succinate. Seventeen suppliers are listed for this compound. Additional details are available on the prucalopride succinate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Prucalopride

A generic version of PRUCALOPRIDE was approved as prucalopride succinate by NOVITIUM PHARMA on December 26th, 2024.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for PRUCALOPRIDE?
  • What are the global sales for PRUCALOPRIDE?
  • What is Average Wholesale Price for PRUCALOPRIDE?
Summary for PRUCALOPRIDE
US Patents:0
Applicants:17
NDAs:17
Drug Prices: Drug price information for PRUCALOPRIDE
DailyMed Link:PRUCALOPRIDE at DailyMed

US Patents and Regulatory Information for PRUCALOPRIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zenara PRUCALOPRIDE SUCCINATE prucalopride succinate TABLET;ORAL 218795-002 Jun 24, 2025 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Teva Pharms Inc PRUCALOPRIDE SUCCINATE prucalopride succinate TABLET;ORAL 219071-002 Feb 5, 2026 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Zydus Lifesciences PRUCALOPRIDE SUCCINATE prucalopride succinate TABLET;ORAL 218056-001 Aug 7, 2025 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Torrent PRUCALOPRIDE SUCCINATE prucalopride succinate TABLET;ORAL 218778-001 Jun 24, 2025 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.